{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:04:11Z","timestamp":1792011851855,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00464-023-10508-w","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T19:02:45Z","timestamp":1698692565000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study"],"prefix":"10.1007","volume":"38","author":[{"given":"Manuel","family":"Dur\u00e1n-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"G\u00f3mez-Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Rodriguez-Ort\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Sanchez-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gord\u00f3n-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Casado-Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Rufi\u00e1n-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Valenzuela-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Rufi\u00e1n-Andujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Carmen","family":"V\u00e1zquez-Borrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Romero-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Brice\u00f1o-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3024-3009","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Arjona-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"issue":"9698","key":"10508_CR1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","volume":"374","author":"BT Hennessy","year":"2009","unstructured":"Hennessy BT, Coleman RL, Markman M (2009) Ovarian cancer. Lancet 374(9698):1371\u20131382","journal-title":"Lancet"},{"issue":"5","key":"10508_CR2","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1245\/s10434-021-11211-7","volume":"29","author":"B Paquette","year":"2022","unstructured":"Paquette B, Kalbacher E, Mercier F, Lakkis Z, Doussot A, Turco C et al (2022) Cytoreductive surgery and intraperitoneal chemotherapy in advanced serous epithelial ovarian cancer: a 14-year French retrospective single-center study of 124 patients. Ann Surg Oncol 29(5):3322\u20133334","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10508_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/annonc\/mdz062","volume":"30","author":"N Colombo","year":"2019","unstructured":"Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I et al (2019) ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol 30(5):672\u2013705","journal-title":"Ann Oncol"},{"issue":"10","key":"10508_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, Kristensen GB, Ehlen T, Johnson N et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363(10):943\u2013953","journal-title":"N Engl J Med"},{"key":"10508_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","volume":"59","author":"A Fagotti","year":"2016","unstructured":"Fagotti A, Ferrandina G, Vizzielli G, Fanfani F, Gallotta V, Chiantera V et al (2016) Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome. Eur J Cancer 59:22\u201333","journal-title":"Eur J Cancer"},{"issue":"9990","key":"10508_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","volume":"386","author":"S Kehoe","year":"2015","unstructured":"Kehoe S, Hook J, Nankivell M, Jayson GC, Kitchener H, Lopes T et al (2015) Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet 386(9990):249\u2013257","journal-title":"Lancet"},{"issue":"3","key":"10508_CR7","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.ygyno.2006.06.025","volume":"103","author":"RE Bristow","year":"2006","unstructured":"Bristow RE, Chi DS (2006) Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecol Oncol 103(3):1070\u20131076","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10508_CR8","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1245\/s10434-009-0558-6","volume":"16","author":"S Kang","year":"2009","unstructured":"Kang S, Nam BH (2009) Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies. Ann Surg Oncol 16(8):2315\u20132320","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10508_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13048-019-0509-1","volume":"12","author":"G Zhang","year":"2019","unstructured":"Zhang G, Zhu Y, Liu C, Chao G, Cui R, Zhang Z (2019) The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis. J Ovarian Res 12(1):33","journal-title":"J Ovarian Res"},{"issue":"1","key":"10508_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354(1):34\u201343","journal-title":"N Engl J Med"},{"issue":"5","key":"10508_CR11","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","volume":"22","author":"J Spiliotis","year":"2015","unstructured":"Spiliotis J, Halkia E, Lianos E, Kalantzi N, Grivas A, Efstathiou E et al (2015) Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol 22(5):1570\u20131575","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10508_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, van Schagen Leeuwen JH, Schreuder HWR, Hermans RHM et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378(3):230\u2013240","journal-title":"N Engl J Med"},{"issue":"13","key":"10508_CR13","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2014.55.9898","volume":"33","author":"D Tewari","year":"2015","unstructured":"Tewari D, Java JJ, Salani R, Armstrong DK, Markman M, Herzog T et al (2015) Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study. J Clin Oncol 33(13):1460\u20131466","journal-title":"J Clin Oncol"},{"issue":"4","key":"10508_CR14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1245\/s10434-016-5686-1","volume":"24","author":"A Di Giorgio","year":"2017","unstructured":"Di Giorgio A, De Iaco P, De Simone M, Garofalo A, Scambia G, Pinna AD et al (2017) Cytoreduction (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: retrospective Italian multicenter observational study of 511 cases. Ann Surg Oncol 24(4):914\u2013922","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10508_CR15","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","volume":"39","author":"N Bakrin","year":"2013","unstructured":"Bakrin N, Bereder JM, Decullier E, Classe JM, Msika S, Lorimier G et al (2013) Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic Intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39(12):1435\u20131443","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10508_CR16","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1245\/s10434-021-11087-7","volume":"29","author":"CCP Antonio","year":"2022","unstructured":"Antonio CCP, Alida GG, Elena GG, Roc\u00edo GS, Jer\u00f3nimo MG, Luis ARJ et al (2022) Cytoreductive surgery with or without HIPEC after neoadjuvant chemotherapy in ovarian cancer: a phase 3 clinical trial. Ann Surg Oncol 29(4):2617\u20132625","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10508_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jamasurg.2022.0143","volume":"157","author":"MC Lim","year":"2022","unstructured":"Lim MC, Chang SJ, Park B, Yoo HJ, Yoo CW, Nam BH et al (2022) Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial. JAMA Surg 157(5):374\u2013383","journal-title":"JAMA Surg"},{"issue":"3","key":"10508_CR18","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00464-018-6352-4","volume":"33","author":"A Arjona-Sanchez","year":"2019","unstructured":"Arjona-Sanchez A, Esquivel J, Glehen O, Passot G, Turaga KK, Labow D et al (2019) A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis. Surg Endosc 33(3):854\u2013860","journal-title":"Surg Endosc"},{"issue":"6","key":"10508_CR19","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.ejso.2020.11.140","volume":"47","author":"A Arjona-Sanchez","year":"2021","unstructured":"Arjona-Sanchez A, Aziz O, Passot G, Salti G, Esquivel J, van der Speeten K et al (2021) Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry. Eur J Surg Oncol 47(6):1420\u20131426","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10508_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/ijgc-2018-000012","volume":"29","author":"A Fagotti","year":"2019","unstructured":"Fagotti A, Gueli Alletti S, Corrado G, Cola E, Vizza E, Vieira M et al (2019) The International Mission study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy. Int J Gynecol Cancer 29(1):5\u20139","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10508_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ygyno.2020.09.052","volume":"160","author":"M Morton","year":"2021","unstructured":"Morton M, Chambers LM, Costales AB, Chichura A, Gruner M, Horowitz MP et al (2021) Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer. Gynecol Oncol 160(1):45\u201350","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10508_CR22","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jmig.2018.09.765","volume":"26","author":"J Brown","year":"2019","unstructured":"Brown J, Drury L, Crane EK, Anderson WE, Tait DL, Higgins RV et al (2019) When less is more: minimally invasive surgery compared with laparotomy for interval debulking after neoadjuvant chemotherapy in women with advanced ovarian cancer. J Minim Invasive Gynecol 26(5):902\u2013909","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"10508_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29\u201342","journal-title":"Ann Surg"},{"issue":"12","key":"10508_CR24","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.3390\/jcm10122553","volume":"10","author":"MT Climent","year":"2021","unstructured":"Climent MT, Serra A, Gilabert-Estell\u00e9s J, Gilabert-Aguilar J, Llueca A (2021) Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in gynecologic malignancies. J Clin Med 10(12):2553","journal-title":"J Clin Med"},{"issue":"9","key":"10508_CR25","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C et al (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 380(9):822\u2013832","journal-title":"N Engl J Med"},{"key":"10508_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.suronc.2019.08.005","volume":"31","author":"\u00c1 Arjona-S\u00e1nchez","year":"2019","unstructured":"Arjona-S\u00e1nchez \u00c1, Dur\u00e1n M, S\u00e1nchez-Hidalgo JM, Rufian-Pe\u00f1a S (2019) Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice. Surg Oncol 31:14\u201315","journal-title":"Surg Oncol"},{"issue":"10","key":"10508_CR27","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s10151-020-02277-8","volume":"24","author":"A Arjona-S\u00e1nchez","year":"2020","unstructured":"Arjona-S\u00e1nchez A, Cort\u00e9s-Guiral D, Duran-Mart\u00ednez M, Villarejo-Campos P, S\u00e1nchez-Hidalgo JM, Casado-Adam A et al (2020) Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy. Tech Coloproctol 24(10):1083\u20131088","journal-title":"Tech Coloproctol"},{"issue":"4","key":"10508_CR28","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00464-020-07572-x","volume":"35","author":"L Rodr\u00edguez-Ortiz","year":"2021","unstructured":"Rodr\u00edguez-Ortiz L, Arjona-S\u00e1nchez A, Iba\u00f1ez-Rubio M, S\u00e1nchez-Hidalgo J, Casado-Adam A, Rufi\u00e1n-Pe\u00f1a S et al (2021) Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis. Surg Endosc 35(4):1778\u20131785","journal-title":"Surg Endosc"},{"key":"10508_CR29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00404-020-05442-4","volume":"301","author":"K Matsuo","year":"2020","unstructured":"Matsuo K, Klar M, Mandelbaum RS, Matsuzaki S, Matsushima K, Roman LD et al (2020) Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for metastatic ovarian cancer: a national study in the United States. Arch Gynecol Obstet 301:863\u2013866","journal-title":"Arch Gynecol Obstet"},{"key":"10508_CR30","unstructured":"U.S. National Library of Medicine (2020) Minimally invasive surgery after neoadjuvant chemotherapy for the treatment of stage IIIC-IV ovarian, primary peritoneal, or fallopian tube cancer, LANCE Trial. Identifier:\u00a0NCT04575935. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04575935?term=laparoscopy&type=Intr&cond=ovarian+cancer&draw=3&rank=57"},{"issue":"5","key":"10508_CR31","doi-asserted-by":"publisher","first-page":"100586","DOI":"10.1016\/j.esmoop.2022.100586","volume":"7","author":"P Filis","year":"2022","unstructured":"Filis P, Mauri D, Markozannes G, Tolia M, Filis N, Tsilidis K (2022) Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials. ESMO Open 7(5):100586","journal-title":"ESMO Open"},{"issue":"10","key":"10508_CR32","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S1470-2045(23)00396-0","volume":"24","author":"SL Aronson","year":"2023","unstructured":"Aronson SL, Lopez-Yurda M, Koole SN, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van Gent MDJM, Arts HJG, van Ham MAPC, van Dam PA, Vuylsteke P, Aalbers AGJ, Verwaal VJ, Van de Vijver KK, Aaronson NK, Sonke GS, van Driel WJ (2023) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial. Lancet Oncol 24(10):1109\u20131118. https:\/\/doi.org\/10.1016\/S1470-2045(23)00396-0","journal-title":"Lancet Oncol"},{"key":"10508_CR33","unstructured":"National Comprehensive Cancer Network (2023) NCCN clinical practice guidelines in oncology. Epithelial ovarian cancer\/fallopian tube cancer\/primary peritoneal cancer. Version 2. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf"},{"key":"10508_CR34","unstructured":"U.S. National Library of Medicine (2020) Multicenter prospective randomized controlled clinical trial of hyperthermic intraperitoneal chemotherapy in the treatment of stage IIc-IV epithelial ovarian cancer after primary cytoreductive surgery. Identifier:\u00a0NCT04280185 https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04280185?term=hyperthermic+intraperitoneal+chemotherapy&cond=Ovarian+Cancer&draw=2&rank=62020"},{"key":"10508_CR35","unstructured":"U.S. National Library of Medicine (2019) Phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer considering two different settings: primary debulking surgery (PDS) and interval debulking surgery (IDS). Identifier:\u00a0NCT03842982 https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03842982?term=hyperthermic+intraperitoneal+chemotherapy&cond=Ovarian+Cancer&draw=2&rank=52019"},{"issue":"4","key":"10508_CR36","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/SLA.0b013e31820784df","volume":"253","author":"J Esquivel","year":"2011","unstructured":"Esquivel J, Averbach A, Chua TC (2011) Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience. Ann Surg 253(4):764\u2013768","journal-title":"Ann Surg"}],"updated-by":[{"DOI":"10.1007\/s00464-023-10576-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000}}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-023-10508-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-023-10508-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-023-10508-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T17:05:23Z","timestamp":1704819923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-023-10508-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10508"],"URL":"https:\/\/doi.org\/10.1007\/s00464-023-10508-w","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00464-023-10576-y","asserted-by":"object"}]},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"5 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00464-023-10576-y","URL":"https:\/\/doi.org\/10.1007\/s00464-023-10576-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Manuel Dur\u00e1n-Mart\u00ednez, Gonzalo G\u00f3mez-Due\u00f1as, Lidia Rodriguez-Ort\u00edz, Juan Manuel Sanchez-Hidalgo, Antonio Gord\u00f3n-Su\u00e1rez, \u00c1ngela Casado-Adam, Sebasti\u00e1n Rufi\u00e1n-Pe\u00f1a, Francisca Valenzuela-Molina, Blanca Rufi\u00e1n-Andujar, Mar\u00eda Carmen V\u00e1zquez-Borrego, Antonio Romero-Ruiz, Javier Brice\u00f1o-Delgado and \u00c1lvaro Arjona-S\u00e1nchez have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}